SCHEMBL6891415

SCHEMBL6891415

O=C(Nc1cc(Cl)cc(Cl)c1)c1cccc(Cl)c1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 4/20 0.68
P2RX4 Q99571 3/20 0.68
P2RX7 Q99572 3/20 0.68
TMPRSS4 Q9NRS4 2/20 0.68
KLKB1 P03952 1/20 0.64
FADS1 O60427 2/20 0.60
PLAU P00749 2/20 0.59
PLAT P00750 2/20 0.59
F2 P00734 1/20 0.59
F10 P00742 1/20 0.59
ALOX15 P16050 1/20 0.59
KDR P35968 1/20 0.58
DHODH Q02127 2/20 0.54
PTGS1 P23219 1/20 0.54
TBXAS1 P24557 1/20 0.54
MAPK1 P28482 1/20 0.54
PTGS2 P35354 1/20 0.54
MAPK14 Q16539 1/20 0.54
TERT O14746 1/20 0.53
KDM4E B2RXH2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4955725 0.87 P2RX1 (0.68) P2RX1P2RX4P2RX7TMPRSS4KLKB1
SCHEMBL28596892 0.85 FADS1 (0.71) P2RX1P2RX4P2RX7TMPRSS4FADS1
SCHEMBL23303282 0.84 P2RX1 (0.64) P2RX1P2RX4P2RX7TMPRSS4KLKB1
SCHEMBL5852388 0.83 KLKB1 (0.72) P2RX1P2RX4P2RX7TMPRSS4KLKB1
SCHEMBL8768715 0.83 PTGS1 (0.68) P2RX1P2RX4P2RX7TMPRSS4KLKB1
SCHEMBL14885879 0.81 P2RX1 (1.00) P2RX1P2RX4P2RX7TMPRSS4KLKB1
SCHEMBL6252378 0.81 P2RX1 (0.58) P2RX1P2RX4P2RX7TMPRSS4FADS1
SCHEMBL30697245 0.81 P2RX1 (0.58) P2RX1P2RX4P2RX7TMPRSS4FADS1
SCHEMBL330755 0.80 FADS1 (0.77) P2RX1P2RX4P2RX7TMPRSS4FADS1
SCHEMBL8672680 0.78 PTGS1 (0.71) P2RX1P2RX4P2RX7FADS1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263657-B2 Blocking neurokinins; using a benzene compound containing hydroxy or acetoxy group; antiinflammatory agents INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2012-09-11 US disclosed
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines NFKBIA, IL1B, IKBKB P2RX1 2316/4885P2RX4 3466/4885P2RX7 1605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.